Hamish John Alexander Hunter
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Research Interests
Hamish John Alexander Hunter has a total of 32 co-authors. Here are the top co-authors by number of shared publications:
- Christine E. Kleyn
Division of Musculoskeletal and Dermatological Sciences NIHR Manchester Biomedical Research Centre The University of Manchester Manchester UK
4 shared publications - Christopher Ernest Maitland Griffiths
Centre for Dermatology Research, NIHR Manchester Biomedical Research Centre, Manchester Academic Health Science Centre University of Manchester Manchester UK
2 shared publications - Ignacio Garcia Doval
Dermatology Department, Complexo Hospitalario Universitario de Vigo , Vigo
2 shared publications - John Walter Frew
Department of Dermatology Liverpool Hospital Liverpool New South Wales Australia
2 shared publications - Luigi Naldi
Dermatology Unit, San Bortolo Hospital, Vicenza
2 shared publications - Alasdair L. Henry
Big Health Ltd., London WC1H 9LT, UK
1 shared publication
Latest Publications
- Open Access
- 21 August 2023
- Published by Oxford University Press (OUP) in British Journal of Dermatology
- Vol. 190 (1) , 1-2
Clinical reports: the overarching home for case series and case reports in the BJD
Ignacio Garcia-Doval, Neil Rajan, Hamish Hunter, John Frew, Luigi Naldi, Jemima E Mellerio, Rod Hay; Clinical reports: the overarching home for case series and
- 21 August 2023
- Published by Oxford University Press (OUP) in British Journal of Dermatology
- Vol. 190 (1) , 1-2
Open AccessClinical reports: the overarching home for case series and case reports in the BJD
Ignacio Garcia-Doval, Neil Rajan, Hamish Hunter, John Frew, Luigi Naldi, Jemima E Mellerio, Rod Hay; Clinical reports: the overarching home for case series and
- 16 February 2022
- Published by Taylor & Francis in Journal of Dermatological Treatment
- Vol. 33 (5) , 2697
Remote consultations: an audit of the management of dermatology patients on biologics during the first wave of the COVID-19 pandemic
Dear Editor,At the beginning of the first wave of the COVID-19 pandemic, hospitals were advised to limit face-to-face patient contact, given the concerns over nosocomial-acquired infection [1]. Fac...
- 16 February 2022
- Published by Taylor & Francis in Journal of Dermatological Treatment
- Vol. 33 (5) , 2697
Remote consultations: an audit of the management of dermatology patients on biologics during the first wave of the COVID-19 pandemic
Dear Editor,At the beginning of the first wave of the COVID-19 pandemic, hospitals were advised to limit face-to-face patient contact, given the concerns over nosocomial-acquired infection [1]. Fac...
- Open Access
- 2 November 2020
- Published by Oxford University Press (OUP) in British Journal of Dermatology
- Vol. 183 (5) , 795-796
The value of case reports in pharmacovigilance
- 2 November 2020
- Published by Oxford University Press (OUP) in British Journal of Dermatology
- Vol. 183 (5) , 795-796
Open AccessThe value of case reports in pharmacovigilance
- 28 June 2020
- Published by Wiley in Journal of the European Academy of Dermatology and Venereology
- Vol. 35 (1) , E45-E47
Diurnal and seasonal variation in psoriasis symptoms
The frequency of itch in people with psoriasis varies between 64‐97% and may exhibit time of day differences as well as interfere with sleep. Furthermore, psoriasis flares appear to exhibit seasonal variation. Whilst a North American study, using a physician‐rating scale, showed a trend for winter flaring and summer clearing; a Japanese study, using proxy measures, found no difference between hot and cold months.
- 28 June 2020
- Published by Wiley in Journal of the European Academy of Dermatology and Venereology
- Vol. 35 (1) , E45-E47
Diurnal and seasonal variation in psoriasis symptoms
The frequency of itch in people with psoriasis varies between 64‐97% and may exhibit time of day differences as well as interfere with sleep. Furthermore, psoriasis flares appear to exhibit seasonal variation. Whilst a North American study, using a physician‐rating scale, showed a trend for winter flaring and summer clearing; a Japanese study, using proxy measures, found no difference between hot and cold months.
- Open Access
- 2 January 2020
- Published by Oxford University Press (OUP) in British Journal of Dermatology
- Vol. 182 (1) , 3-4
Reopening the case for case reports
- 2 January 2020
- Published by Oxford University Press (OUP) in British Journal of Dermatology
- Vol. 182 (1) , 3-4
Open AccessReopening the case for case reports
- 18 December 2019
- Published by Oxford University Press (OUP) in British Journal of Dermatology
- Vol. 182 (2) , 276-277
Remember to assess the ‘whole’ patient: a further immune‐related adverse event of programmed cell death 1 checkpoint inhibition
- 18 December 2019
- Published by Oxford University Press (OUP) in British Journal of Dermatology
- Vol. 182 (2) , 276-277
Remember to assess the ‘whole’ patient: a further immune‐related adverse event of programmed cell death 1 checkpoint inhibition
- 25 June 2019
- Published by Oxford University Press (OUP) in British Journal of Dermatology
- Vol. 181 (3) , 445-446
What's the point in checking the skin?
- 25 June 2019
- Published by Oxford University Press (OUP) in British Journal of Dermatology
- Vol. 181 (3) , 445-446
What's the point in checking the skin?
- 26 September 2017
- Published by Wiley in Experimental Dermatology
- Vol. 26 (10) , 972-985
FRT – FONDATION RENE TOURAINE
- 26 September 2017
- Published by Wiley in Experimental Dermatology
- Vol. 26 (10) , 972-985
FRT – FONDATION RENE TOURAINE
- 18 April 2017
- Published by Oxford University Press (OUP) in British Journal of Dermatology
- Vol. 176 (4) , 864-865
Can positron emission tomography (PET) unravel the link between adipose tissue, vascular inflammation and cardiovascular risk in patients with psoriasis?
- 18 April 2017
- Published by Oxford University Press (OUP) in British Journal of Dermatology
- Vol. 176 (4) , 864-865
Can positron emission tomography (PET) unravel the link between adipose tissue, vascular inflammation and cardiovascular risk in patients with psoriasis?
- 25 March 2015
- Published by Oxford University Press (OUP) in Clinical and Experimental Dermatology
- Vol. 40 (5) , 540-546
The impact of psychosocial stress on healthy skin
Dermatologists are only too aware of the significant role psychosocial stress plays in the exacerbation of skin disease; indeed, it is often the first precipitant patients mention when they attend outpatient clinics. Of late, research has focused on understanding the 'brain-skin' axis, a complex interplay between the nervous and immune systems and the skin. In particular, there is an evolving body of literature exploring the underlying pathophysiological mechanisms by which psychosocial stress influences skin homeostasis. This article provides a broad overview of the literature, emphasizing the importance of individual stress perception and summarizing the varied roles of the major cutaneous stress-response pathways. Both central [the hypothalamic-pituitary-adrenal (HPA) axis and the locus ceruleus-norepinephrine (LC-NE) sympathetic adrenomedullary system] and peripheral (the intracutaneous HPA axis and the release of mediators from peripheral sensory and autonomic nerves) pathways are discussed. Moreover, how activation of these pathways affects the skin's immune system, barrier function, wound healing and susceptibility to infection is reviewed. Although this field of research is rapidly expanding, several important questions remain unanswered, including: what is the precise role of mast cells in the cutaneous stress response?; what is the role of regulatory T-cells?; can therapeutic intervention be harnessed to prevent the stress-induced exacerbation of skin disease? It is anticipated that an improved understanding of the underlying mechanisms through which psychosocial stress affects the homeostasis of healthy skin will not only increase knowledge of the brain-skin axis but will also improve the holistic management of stress-responsive cutaneous disease.
- 25 March 2015
- Published by Oxford University Press (OUP) in Clinical and Experimental Dermatology
- Vol. 40 (5) , 540-546
The impact of psychosocial stress on healthy skin
Dermatologists are only too aware of the significant role psychosocial stress plays in the exacerbation of skin disease; indeed, it is often the first precipitant patients mention when they attend outpatient clinics. Of late, research has focused on understanding the 'brain-skin' axis, a complex interplay between the nervous and immune systems and the skin. In particular, there is an evolving body of literature exploring the underlying pathophysiological mechanisms by which psychosocial stress influences skin homeostasis. This article provides a broad overview of the literature, emphasizing the importance of individual stress perception and summarizing the varied roles of the major cutaneous stress-response pathways. Both central [the hypothalamic-pituitary-adrenal (HPA) axis and the locus ceruleus-norepinephrine (LC-NE) sympathetic adrenomedullary system] and peripheral (the intracutaneous HPA axis and the release of mediators from peripheral sensory and autonomic nerves) pathways are discussed. Moreover, how activation of these pathways affects the skin's immune system, barrier function, wound healing and susceptibility to infection is reviewed. Although this field of research is rapidly expanding, several important questions remain unanswered, including: what is the precise role of mast cells in the cutaneous stress response?; what is the role of regulatory T-cells?; can therapeutic intervention be harnessed to prevent the stress-induced exacerbation of skin disease? It is anticipated that an improved understanding of the underlying mechanisms through which psychosocial stress affects the homeostasis of healthy skin will not only increase knowledge of the brain-skin axis but will also improve the holistic management of stress-responsive cutaneous disease.